Doorgaan naar hoofdnavigatie
Doorgaan naar zoeken
Ga verder naar hoofdinhoud
de research portal van de Rijksuniversiteit Groningen Startpagina
Help en veelgestelde vragen
English
Nederlands
Startpagina
Profielen
Onderzoekseenheden
Onderzoeksoutput
Activiteiten
Datasets
Pers/Media
Projecten
Prijzen
Zoeken op expertise, naam of affiliatie
Bekijk Scopus-profiel
Gerwin Huls
prof. dr.
https://orcid.org/0000-0002-7120-898X
Overzicht
Vingerafdruk
Netwerk
Onderzoeksoutput
(182)
Activiteiten
(13)
Datasets
(1)
Pers/Media
(3)
Soortgelijke profielen
(12)
Begeleid werk
(19)
Begeleid werk
Onderzoeksoutput per jaar
Begeleid werk per jaar
Onderzoekersresultaten
19 resultaten
Publicatiejaar, Titel
(aflopend)
Publicatiejaar, Titel
(oplopend)
Titel
Type
Zoekresultaten
2025
Dissecting the Molecular Landscape of Acute Myeloid Leukemia: From Inflammatory Niches to DNA Damage Responses
Sheveleva, S.
,
2025
, [Groningen]:
University of Groningen
.
209 blz.
Onderzoeksoutput
Open Access
Bestand
Myeloid
100%
DNA Damage Response
100%
DNMT3A
60%
PCGF1
50%
Stem Cell
40%
206
Downloads (Pure)
Multifaceted approaches to tumor microenvironment modulation and immune checkpoint targeting
Melo Gallegos, V. A.,
2025
, [Groningen]:
University of Groningen
.
211 blz.
Onderzoeksoutput
Open Access
Bestand
Immune Checkpoint
100%
Tumor Microenvironment
100%
Tumor Microenvironment Modulation
100%
Immunocompetent Cell
100%
Immunity
100%
158
Downloads (Pure)
2024
Blood count abnormalities and evolution of clonal hematopoiesis
van Zeventer, I.
,
2024
, [Groningen]:
University of Groningen
.
292 blz.
Onderzoeksoutput
Open Access
Bestand
Blood Cell Count
100%
Hematopoiesis
100%
Hematopoietic Stem Cell
40%
Somatic Mutation
40%
Dynamics
20%
547
Downloads (Pure)
Decitabine in the treatment of acute myeloid leukemia: clinical aspects and immunological opportunities
Hilberink, J. R.
,
2024
, [Groningen]:
University of Groningen
.
197 blz.
Onderzoeksoutput
Open Access
Bestand
Acute Myeloid Leukemia
100%
Clinical Aspects
100%
Decitabine
100%
Leukaemia Clinical
100%
Clinical Feature
100%
272
Downloads (Pure)
Exploring novel immune checkpoints and targeted delivery strategies for ovarian cancer therapy
Bilemjian, V.,
2024
, [Groningen]:
University of Groningen
.
159 blz.
Onderzoeksoutput
Open Access
Bestand
Immune Checkpoint
100%
Targeted Delivery
100%
Ovarian Cancer Screening
100%
Epithelial Ovarian Cancer
100%
Delivery Strategy
100%
164
Downloads (Pure)
Navigating hypoxia and amino acid signatures in Acute Myeloid Leukemia
Cunningham, A.,
2024
, [Groningen]:
University of Groningen
.
238 blz.
Onderzoeksoutput
Open Access
Bestand
Amino Acids
100%
Myeloid
100%
Methionine
100%
Amino Acid
100%
Amino Acid Signature
100%
290
Downloads (Pure)
Navigating the path of Cancer Immunotherapeutics: Novel Targets and Innovative Development Tools
Álvarez Freile, J.
,
2024
, [Groningen]:
University of Groningen
.
190 blz.
Onderzoeksoutput
Open Access
Bestand
Immune Checkpoint Inhibitors
100%
Immune Checkpoint
100%
CD24
100%
Development Tools
100%
Innovative Development
100%
389
Downloads (Pure)
Towards improving cancer immunotherapy: development of novel antibody-based therapeutics and drug delivery systems
Nelemans, L. C.,
2024
, [Groningen]:
University of Groningen
.
171 blz.
Onderzoeksoutput
Open Access
Bestand
Malignant Neoplasm
100%
Drug Delivery System
100%
Immunotherapy
100%
Cancer Immunotherapy
100%
Nanoparticle
100%
56
Downloads (Pure)
2023
Advancing Cancer Immunotherapy with Nanomedicine
Choukrani, G.,
2023
, [Groningen]:
University of Groningen
.
207 blz.
Onderzoeksoutput
Open Access
Bestand
T Cell Activation
100%
Cancer Immunotherapy
100%
Immunoglobulin Domain
100%
Malignant Neoplasm
100%
Immunotherapy
100%
788
Downloads (Pure)
BH3 profiling to optimize lymphoma treatment: Pre-clinical studies
Langendonk, M.,
2023
, [Groningen]:
University of Groningen
.
171 blz.
Onderzoeksoutput
Open Access
Bestand
Clinical Study
100%
Antiapoptotic
100%
Malignant Neoplasm
100%
Preclinical Study
100%
Cancer Cell
100%
366
Downloads (Pure)
Novel T cell biomarkers and the development of immunotherapeutic anti-tumor strategies
Vlaming, M.,
2023
, [Groningen]:
University of Groningen
.
273 blz.
Onderzoeksoutput
Open Access
Bestand
T Cells
100%
Cancer Types
100%
Immunotherapeutics
100%
Antitumor
100%
Cellular Biomarkers
100%
540
Downloads (Pure)
Towards personalized cancer management: diagnosis and (immuno)therapy
Lin, Y.,
2023
, [Groningen]:
University of Groningen
.
239 blz.
Onderzoeksoutput
Open Access
Bestand
Macrophage
100%
Intravenous Immunoglobulin
100%
Trastuzumab
100%
T Cell
50%
RNA
50%
380
Downloads (Pure)
2022
Immunophenotyping of Acute Myeloid Leukemia
Houtsma, R.,
2022
, [Groningen]:
University of Groningen
.
159 blz.
Onderzoeksoutput
Open Access
Bestand
Myeloid
100%
CD200
60%
Stem Cell
40%
Mitochondrial Transfer
25%
Patient Coding
20%
701
Downloads (Pure)
Innate immune checkpoint inhibitors for treatment of Diffuse Large B-cell Lymphoma
Bouwstra, R.,
2022
, [Groningen]:
University of Groningen
.
219 blz.
Onderzoeksoutput
Open Access
Bestand
Immune Checkpoint Inhibitors
100%
Diffuse Large B-cell Lymphoma (DLBCL)
100%
Innate Immune Checkpoint
100%
B Cell
100%
Immune Checkpoints
100%
1081
Downloads (Pure)
Uncovering metabolic profiles in Acute Myeloid Leukemia: from metabolic drivers to metabolic adaptations
Erdem, A.,
2022
, [Groningen]:
University of Groningen
.
212 blz.
Onderzoeksoutput
Open Access
Bestand
Myeloid
100%
Stem Cell
37%
Genetics
25%
Metabolic Pathway
25%
Molecular Biology
12%
679
Downloads (Pure)
2021
Health-related quality of life in thyroid and blood disorders
Wouters, H.,
2021
, [Groningen]:
University of Groningen
.
291 blz.
Onderzoeksoutput
Open Access
Bestand
Health-related Quality of Life
100%
Thyroid Disorders
100%
Blood Disorders
100%
Hematologic Disease
100%
Thyroid Disease
100%
1460
Downloads (Pure)
Molecular imaging in diagnostics and therapy of lymphoprolifertive disorders
Kahle, X.,
2021
, [Groningen]:
University of Groningen
.
223 blz.
Onderzoeksoutput
Open Access
Bestand
Lymphoma
100%
Molecular Imaging
100%
Disease
100%
Diagnosis
100%
Molecular Processes
40%
445
Downloads (Pure)
2016
New treatment strategies in myelodysplastic syndromes and acute myeloid leukemia: Hypomethylating agents and proteasome inhibitors
van der Helm, L. H.,
2016
, [Groningen]:
Rijksuniversiteit Groningen
.
164 blz.
Onderzoeksoutput
Open Access
Bestand
Acute Myeloid Leukemia
100%
Protease Inhibitors
100%
New Treatment Options
100%
Myelodysplastic Syndrome
100%
Azacitidine
100%
2885
Downloads (Pure)
2013
The biology of human hematopoietic stem and progenitor cells in acute myeloid leukemia, aging and autologous transplantation
Woolthuis, C. M.
,
2013
, Groningen:
s.n.
.
216 blz.
Onderzoeksoutput
Open Access
Bestand
3342
Downloads (Pure)